Table 3 Gender-specific comorbidities, urbanization, and hospital level for 1078 patients with Dupuytren’s disease in Taiwan
Variables | Total = 1078 (100%) | Male = 681 (100%) | Female = 397 (100%) | *p |
|---|---|---|---|---|
Comorbidities (n (%)) | ||||
Hypertension | 319 (29.6) | 231 (33.9) | 88 (22.2) | <0.0001$ |
Diabetes mellitus | 236 (21. 9) | 163 (23.9) | 73 (18.4) | 0.0336$ |
Hyperlipidemia | 159 (14.8) | 95 (14.0) | 64 (16.1) | 0.3323$ |
Ischemic heart disease | 113 (10.5) | 83 (12.2) | 30 (7. 6) | 0.0167$ |
COPD | 86 (8.0) | 74 (10.9) | 12 (3.0) | <0.0001$ |
Stroke | 54 (5.0) | 40 (5.9) | 14 (3.5) | 0.0884$ |
Cancers | 37 (3.4) | 26 (3.8) | 11 (2.8) | 0.3624$ |
Hepatitis (B or C) | 17 (1.6) | 11 (1.6) | 6 (1.5) | 0.8949$ |
CKD | 21 (2.0) | 11 (1.6) | 10 (2.5) | 0.3005$ |
Rheumatic disease | 14 (1.3) | 3 (0.4) | 11 (2.8) | 0.0017& |
Pulmonary tuberculosis | 8 (0.7) | 5 (0.7) | 3 (0.8) | 1.0000& |
Valvular heart disease | 7 (0.7) | 5 (0.7) | 2 (0.5) | 0.6496& |
Alcoholism | 1 (0.1) | 1 (0.2) | 0 (0.0) | 1.0000& |
Urbanization | 0.0980$ | |||
1 (highest) | 275 (25.5) | 179 (26.3) | 96 (24.2) | |
2 | 567 (52.6) | 366 (53.7) | 201 (50.6) | |
3 | 38 (3.5) | 17 (2.5) | 21 (5.3) | |
4 | 171 (15.9) | 101 (14.8) | 70 (17.6) | |
≥5 | 27 (2.5) | 18 (2.6) | 9 (2.3) | |
Hospital location | 0.4407$ | |||
1. North | 579 (53.7) | 375 (55.1) | 204 (51.4) | |
2. Central | 158 (14.7) | 95 (14.0) | 63 (15.9) | |
3. South | 316 (29.3) | 193 (28.34) | 123 (31.0) | |
4. East | 25 (2.3) | 18 (2.6) | 7 (1.8) |